The Brain & Behavior Research Foundation (BBRF) invites the public to a free webinar, “Developing a Potential New Treatment for Chronic PTSD: Ketamine Combined with Written Exposure Therapy” on ...

Transcend Therapeutics’ Phase II IMPACT-1 study examining its neuroplastigen treatment for post-traumatic stress disorder ...

Transcend also saw significant improvements on secondary endpoints that assessed the rate of response, remission and loss of ...

A relatively new treatment addresses "the root cause of anxiety, depression, PTSD, and Long COVID symptoms," according to the ...

Ex-Intel head says TSMC’s new investment will not resurrect US chip sector ...

Healing from PTSD doesn’t have to be complicated. Explore how nature, movement, and mindset can help veterans reset and rebuild.

Transcend Therapeutics’ PTSD treatment succeeded in a mid-stage study, propelling the scrappy company of less than 20 people toward a Phase 3 study that could begin at the start of next year.

People with post-traumatic stress disorder (PTSD) symptoms often have trouble communicating and resolving relationship ...

Witnessing trauma changes the brain differently than experiencing it, needing tailored PTSD treatment approaches.